First case of COVID-19 in a kidney transplant recipient treated with belatacept

David Marx; Bruno Moulin; Samira Fafi-Kremer; Ilies Benotmane; Gabriela Gautier; Peggy Perrin; Sophie Caillard

doi:10.1111/ajt.15919

First case of COVID-19 in a kidney transplant recipient treated with belatacept

Am J Transplant. 2020 Jul;20(7):1944-1946. doi: 10.1111/ajt.15919. Epub 2020 Apr 28.

Authors

David Marx¹, Bruno Moulin¹, Samira Fafi-Kremer², Ilies Benotmane^{1

2}, Gabriela Gautier¹, Peggy Perrin¹, Sophie Caillard¹

Affiliations

¹ Department of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France.
² Department of Virology, Strasbourg University Hospital, Strasbourg, France.

No abstract available

Keywords: clinical research/practice; immunosuppressant; immunosuppression/immune modulation; infection and infectious agents-viral; infectious disease; kidney transplantation/nephrology.

Publication types

Case Reports
Letter

MeSH terms

Abatacept / administration & dosage*
COVID-19
Coronavirus Infections / complications*
Coronavirus Infections / diagnostic imaging
Coronavirus Infections / drug therapy*
Cyclosporine / administration & dosage
Humans
Immunosuppression Therapy / adverse effects*
Immunosuppressive Agents / administration & dosage
Kidney Failure, Chronic / complications*
Kidney Failure, Chronic / surgery
Kidney Transplantation*
Lung / diagnostic imaging
Male
Middle Aged
Mycophenolic Acid / administration & dosage
Pandemics
Pneumonia, Viral / complications*
Pneumonia, Viral / diagnostic imaging
Pneumonia, Viral / drug therapy*
Prednisone / administration & dosage
Radiography, Thoracic
Tomography, X-Ray Computed
Treatment Outcome

Substances

Immunosuppressive Agents
Abatacept
Cyclosporine
Mycophenolic Acid
Prednisone